Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hemogenyx Pharmaceuticals Plc (LSE: HEMO)

 
HEMO Technical Analysis
4
As on 28th Nov 2025 HEMO STOCK Price closed @ 594.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 393.42 & Strong Buy for SHORT-TERM with Stoploss of 291.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

HEMOSTOCK Price

Open 680.00 Change Price %
High 680.00 1 Day -102.00 -14.66
Low 590.00 1 Week -286.00 -32.50
Close 594.00 1 Month -374.00 -38.64
Volume 67517 1 Year 592.82 50238.98
52 Week High 1545.00 | 52 Week Low 1.02
 
LSE UK Most Active Stocks
UKOG 0.01 0.00%
MSMN 0.02 0.00%
DEMG 0.02 -50.00%
SMDS 582.50 0.00%
DKE 0.15 0.00%
NNN 0.09 50.00%
GST 0.78 0.00%
DMTR 0.03 0.00%
BOIL 0.08 0.00%
OBD 0.26 -13.33%
 
LSE UK Top Gainers Stocks
BIOM 7.78 937.33%
0YY7 20.40 280.60%
SSIF 18.50 208.33%
0QWC 20.60 152.14%
CGW 55.03 107.66%
GILD 0.08 100.00%
GILD 0.08 100.00%
GILD 0.08 100.00%
0QTF 0.17 88.89%
CNN 65.00 85.71%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0IHM 30.73 -79.82%
 
 
HEMO
Daily Charts		 HEMO
Intraday Charts		 Whats New @
Bazaartrend		 HEMO
Free Analysis
 
HEMO Important Levels Intraday
RESISTANCE767.43
RESISTANCE711.81
RESISTANCE677.43
RESISTANCE643.05
SUPPORT544.95
SUPPORT510.57
SUPPORT476.19
SUPPORT420.57
 
HEMO Forecast November 2025
Share
4th UP Forecast819.9
3rd UP Forecast747.45
2nd UP Forecast702.67
1st UP Forecast657.89
1st DOWN Forecast530.11
2nd DOWN Forecast485.33
3rd DOWN Forecast440.55
4th DOWN Forecast368.1
 
HEMO Weekly Forecast
4th UP Forecast1312.77
3rd UP Forecast1082.26
2nd UP Forecast939.77
1st UP Forecast797.29
1st DOWN Forecast390.72
2nd DOWN Forecast248.23
3rd DOWN Forecast105.74
4th DOWN Forecast-124.77
 
HEMO Forecast2025
4th UP Forecast4060.87
3rd UP Forecast2949.02
2nd UP Forecast2261.77
1st UP Forecast1574.51
1st DOWN Forecast-386.51
2nd DOWN Forecast-1073.77
3rd DOWN Forecast-1761.02
4th DOWN Forecast-2872.87
 
 
HEMO Other Details
Segment EQ
Market Capital 18894460.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
HEMO Address
HEMO
 
HEMO Latest News
 
Your Comments and Response on Hemogenyx Pharmaceuticals Plc
 
HEMO Business Profile
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company is developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; CAR-T therapy, a chimeric antigen receptor T-cells for use in immunotherapy, as well as for R/R AML; and Human Postnatal Hemogenic Endothelial Cells, a stem cell therapy product for BM/HSC transplants. Hemogenyx Pharmaceuticals Plc has a collaboration with GlobalCo. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. Address: 5 Fleet Place, London, United Kingdom, EC4M 7RD
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service